1Kauh YG , Zachian TF. Melasma[A]. In:Mallia C. Uitto J, Rheumaderm[M]. New York: Kluwer Academic/Plenum,1999.491- 499.
2Palumh A, Dischia M,Misuraca G. Mechznism of inhibition of melanogenesis by hydroquinone[J]. Biochem Biophys Acta,1991,1073:85-90.
3Salopek TG,Jimbow K.New treatment options for the patient with facial hyperpigmentation[J]. Curr Opin Dermatol,1995,61-68.
4Verallo-Rowell VM, Verallo V, Graupe K,et al. Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma [J]. Acta Derm Venereol Suppl ,1989,143:58- 61.
5Balina LM,Graupe K.The treament of melasma: 20% azelaic acid versus 4% hydroquinone cream[J].Int J Dermatol ,1991,30:893- 895.
6Bahawan J. Short-and long-term histologic effects of topical tretinoin on photodamaged skin[J].Int J Dermatol ,1998,37:286- 292.
7Bulengo-Ransby SM,Griffiths CE,Kimbrough-Green CK,et al.Topical tretinoin(retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients[J]. N Engl J Med ,1993,328:1438- 1443.
8Orlow SJ, Dhakraborth AK,Pawelek JM. Retinoic acid is a potent inhibitor of inducible pigmentation in murine and hamster milanoma cell lines[J].J Invest Dermatol ,1990,94:461- 464.
9Mishima Y, Hatta S, Ohyama Y,et al. Induction of melanogenesis suppression: celluar pharmacology and mode of differential action[J]. Pigment Cell Res ,1988,1:367- 374.
10Kahn V. Effect of kojic acid on the oxidation of Dl-DOPA, norepinephine, and dopamine by mushroom tyrosinase[J]. Pigment Cell Res ,1995,8:234- 240.
